METHOD FOR EVALUATING THE EFFICACY OF AN EGFR-TKI TREATMENT

摘要

The present invention provides a method for evaluating the efficacy of an EGFR-TKI treatment to an object, comprising identifying the V384D mutation in said object. By identifying said mutation, the efficacy of the EGFR-TKI treatment and the progression-free survival of said object after treatment can be estimated.